CMS Lets Michigan Use Outcome-Based Medicaid Rx Drug Contracts

Michigan has become the second state to gain CMS permission to enter into outcome-based contracts with drug manufacturers under its Medicaid program, CMS Administrator Seema Verma announced at the Prevision Policy Biopharma Congress on Tuesday. Michigan submitted its request for a State Plan Amendment less than two months ago, as Inside Health Policy previously reported . Outcome-based contracts could force drug manufacturers to pay additional rebates if the drugs do not meet specified treatment benchmarks for patients. “I applaud...